INDIANAPOLIS, Indiana
United States
17
2018-07-26
12
2020-09-08
These are the the leading inventors for applications assigned to IMCLONE LLC:
IMCLONE LLC based in INDIANAPOLIS, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMBINATION THERAPY FOR CANCER
#2 | 2017-11-23DOSING REGIMEN
#3 | 2017-08-10 ✅ Patent 10,766,961 granted on 2020-09-08Anti-VEGFR2 antibody therapy for hepatocellular carcinoma
#4 | 2017-05-18THERAPY FOR GIST
#5 | 2017-05-11COMBINATION THERAPY
#6 | 2015-06-18 ✅ Patent 9,375,488 granted on 2016-06-28Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment
#7 | 2013-10-24 ✅ Patent 8,784,818 granted on 2014-07-22Anti-VEGFR-3 antibody compositions
#8 | 2012-11-15 ✅ Patent 8,552,157 granted on 2013-10-08c-Kit antibodies and uses thereof
#9 | 2012-08-30 ✅ Patent 8,404,240 granted on 2013-03-26Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#10 | 2012-07-12ANTI-TGF-BETA RECEPTOR II ANTIBODIES
#11 | 2012-05-17 ✅ Patent 8,263,074 granted on 2012-09-11Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
#12 | 2012-03-08 ✅ Patent 8,481,034 granted on 2013-07-09Anti-VEGFR-3 antibody compositions
#13 | 2012-02-09 ✅ Patent 8,425,911 granted on 2013-04-23Methods of treating secondary bone tumors with antibodies against PDGFR alpha
#14 | 2012-02-02 ✅ Patent 8,574,578 granted on 2013-11-05Antibodies against PDGFRα to inhibit tumor growth
#15 | 2012-01-12 ✅ Patent 8,182,815 granted on 2012-05-22Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#16 | 2011-11-03 ✅ Patent 8,143,025 granted on 2012-03-27Antibodies against vascular endothelial growth factor receptor-1
#17 | 2011-10-06 ✅ Patent 8,263,079 granted on 2012-09-11Antibodies against CSF-1R
Also check out ImClone LLC's (Indianapolis, United States) applicant profile with 3 patent applications submitted.
94135 ⎘